Cargando…
Diagnosis and biomarkers of predementia in Alzheimer's disease
In view of the growing prevalence of Alzheimer's disease (AD) worldwide, there is an urgent need for the development of better diagnostic tools and more effective therapeutic interventions. At the earliest stages of AD, no significant cognitive or functional impairment is detected by convention...
Autores principales: | Forlenza, Orestes V, Diniz, Breno S, Gattaz, Wagner F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022870/ https://www.ncbi.nlm.nih.gov/pubmed/21176189 http://dx.doi.org/10.1186/1741-7015-8-89 |
Ejemplares similares
-
Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia
por: Forlenza, Orestes V., et al.
Publicado: (2015) -
Plasma Biomarkers of Alzheimer’s Disease: A Review of Available Assays, Recent Developments, and Implications for Clinical Practice
por: Pais, Marcos V., et al.
Publicado: (2023) -
Decision tree-based classification as a support to diagnosis in the Alzheimer’s disease continuum using cerebrospinal fluid biomarkers: insights from automated analysis
por: Costa, Alana, et al.
Publicado: (2022) -
Cerebral perfusion in the predementia stages of Alzheimer’s disease
por: Binnewijzend, Maja A. A., et al.
Publicado: (2015) -
Neurobiological pathways to Alzheimer’s disease: Amyloid-beta, TAU
protein or both?
por: de Paula, Vanessa de Jesus R., et al.
Publicado: (2009)